Evidence map›Paper›PMID 23230240›Full record

ArticleCephalalgia : an international journal of headache2013

Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role?

Ann I Scher, Gudny Eiriksdottir, Melissa Garcia, Preethy Feit, Albert V Smith, Tamara B Harris, Kathryn A Roecklein, Larus S Gudmundsson, Vilmundur Gudnason, Lenore J Launer

Open access · greenAbstract read
In one paragraph

Article in Cephalalgia : an international journal of headache, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ann I ScherDepartment of Preventive Medicine and Biometrics, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. ann.scher@usuhs.edu
Gudny Eiriksdottir
Melissa Garcia
Preethy Feit
Albert V Smith
Tamara B Harris
Kathryn A Roecklein
Larus S Gudmundsson
Vilmundur Gudnason
Lenore J Launer
National Institute on Aging · USIcelandic Heart Association · ISUniformed Services University of the Health Sciences · USUniversity of Iceland · ISUniversity of Pittsburgh · US

Funding

Genetic Markers of Brain AgingZIAAG007270 · NIA · NATIONAL INSTITUTE ON AGING · PI LAUNER, LENORE J · 2009 to 2025
$2.7M
The impact of migraine on the aging brainZIAAG007260 · NIA · NATIONAL INSTITUTE ON AGING · PI LAUNER, LENORE J · 2011 to 2016
$249k
AGES STUDY-THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENNIUM-26012100N01AG012100 · NIA · ICELANDIC HEART ASSOCIATION · 2002 to 2004
–
Intramural NIH HHS ZIA AG007260NIA NIH HHS N01 AG012100NIA NIH HHS N01-AG-1-2100
6 · The paper itself

Abstract

backgroundSeveral studies, but not all, of primarily middle-aged or younger adults have suggested that the common MTHFR C677T variant is a genetic risk factor for migraine with aura (MA). Here, we consider whether this variant is associated with MA risk in an older non-clinical population (AGES-Reykjavik cohort).

methodsParticipants are a sub-sample ( N  = 1976) of subjects from the Reykjavik Study (RS; mean age 50) and its continuation, AGES-RS (mean age 76). We estimated the relative odds of MA in TT versus CC carriers using multinomial logistic regression. As both MA and the TT genotype may be linked with modestly reduced longevity, we performed a simple simulation to illustrate the effect that selective survival may have had on our observed gene-disease association.

resultsTT versus CC carriers were at marginally reduced odds of MA (ORTT 0.55 (0.3-1.0), P  = 0.07), significantly for women (ORTT 0.45 (0.2-0.9), P  = 0.03). Assuming the 'true' (e.g. mid-life) effect of the TT genotype is ORTT 1.26, from a recent meta-analysis, our simulation suggested that if 25-year mortality had been (hypothetically) 13% higher in MA subjects with the TT versus CC genotype, the measured effect of the TT genotype on MA would have been attenuated to non-significance (e.g. ORTT 1.00). Our observed protective effect was consistent with the most extreme selective mortality scenario, in which essentially all of the previously reported increased mortality in MA subjects was (hypothetically) found in CT or TT carriers.

conclusionThe MTHFR 677TT genotype was associated with marginally reduced risk of MA in our older population. Our simulation illustrated how even modest selective survival might obscure the apparent effect of a genetic or other risk factor in older populations. We speculate that some of the heterogeneity previously observed for this particular genetic variant may be due to age range differences in the studied populations.

Indexed as

MutationAgedAged, 80 and overFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMethylenetetrahydrofolate Reductase (NADPH2)Migraine with AuraOdds RatioPolymorphism, Single NucleotideMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, human

Identifiers

PMID23230240
PMCPMC4532672
OpenAlexW2157683655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.